Na skróty
Rozpocznij rozmowę z konsultantem Wyślij swoje pytanie
Money.plGiełda w Money.plKomunikaty ze spółekKomunikaty ze świata
Wiadomości ze spółek na świecie (ang.)
Data Państwo Firma Typ informacji Tytuł
2012-03-21 07:30:00 Switzerland Addex Pharmaceuticals Addex Changes Name to Addex Therapeutics, Launches New Website and Corporate Branding Addex Changes Name to Addex Therapeutics, Launches New Website and Corporate Branding
2012-02-23 07:00:00 Switzerland Addex Pharmaceuticals Addex Pharmaceuticals Reports 2011 Financial Results Addex Pharmaceuticals Reports 2011 Financial Results
2012-02-21 18:00:00 Switzerland Addex Pharmaceuticals Addex Pharmaceuticals 2011 Financial Results This Thursday Addex Pharmaceuticals 2011 Financial Results This Thursday
2012-02-10 07:00:00 Switzerland Addex Pharmaceuticals Addex to Present at the BIO CEO & Investor Conference Addex to Present at the BIO CEO & Investor Conference
2011-11-28 07:00:00 Switzerland Addex Pharmaceuticals Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Receptors Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Receptors
2011-11-02 07:00:00 Switzerland Addex Pharmaceuticals Addex Presents Data on Allosteric Modulators of GPCRs at the Discovery on Target Conference Addex Presents Data on Allosteric Modulators of GPCRs at the Discovery on Target Conference
2011-10-24 07:01:00 Switzerland Addex Pharmaceuticals Addex to Present at the BIO Investor Forum in San Francisco Addex to Present at the BIO Investor Forum in San Francisco
2011-10-19 18:00:00 Switzerland Addex Pharmaceuticals Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters
2011-10-03 18:00:00 Switzerland Addex Pharmaceuticals Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders
2011-09-26 07:01:00 Switzerland Addex Pharmaceuticals Addex to Present at the Jefferies 2011 Global Healthcare Conference in London Addex to Present at the Jefferies 2011 Global Healthcare Conference in London
2011-09-02 18:05:00 Switzerland Addex Pharmaceuticals Addex Regains Rights to Parkinson's Drug Candidates from Merck Addex Regains Rights to Parkinson's Drug Candidates from Merck
2011-08-15 07:00:00 Switzerland Addex Pharmaceuticals Addex Pharmaceuticals Appoints Dr Bharatt Chowrira as CEO Addex Pharmaceuticals Appoints Dr Bharatt Chowrira as CEO
2011-08-11 07:00:00 Switzerland Addex Pharmaceuticals Addex Pharmaceuticals Announces Board Changes Addex Pharmaceuticals Announces Board Changes
2011-07-27 07:01:00 Switzerland Addex Pharmaceuticals Addex Pharmaceuticals First Half 2011 Financial Results Addex Pharmaceuticals First Half 2011 Financial Results
2011-07-20 18:01:00 Switzerland Addex Pharmaceuticals Addex Pharmaceuticals First Half Financial Results on July 27 Addex Pharmaceuticals First Half Financial Results on July 27
2011-07-07 10:00:00 Switzerland Addex Pharmaceuticals Addex Announces Corporate Reorganization and Restructuring Initiative to Strengthen Its Leadership Position in Allosteric Modulation-Based Drug Discovery and Development Addex Announces Corporate Reorganization and Restructuring Initiative to Strengthen Its Leadership Position in Allosteric Modulation-Based Drug Discovery and Development
2011-06-03 07:04:00 Switzerland Addex Pharmaceuticals Addex Pharmaceuticals CEO Steps Down Addex Pharmaceuticals CEO Steps Down
2011-04-28 18:01:00 Switzerland Addex Pharmaceuticals Addex Shareholders Appoint Hoyoung Huh and Oleg Nodelman to Board, Approve All Board Proposals at Annual General Meeting Addex Shareholders Appoint Hoyoung Huh and Oleg Nodelman to Board, Approve All Board Proposals at Annual General Meeting
2011-03-31 07:00:00 Switzerland Addex Pharmaceuticals Addex Initiates Phase IIa Clinical Trial of Dipraglurant-IR in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID) Addex Initiates Phase IIa Clinical Trial of Dipraglurant-IR in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID)
2011-03-28 07:01:00 Switzerland Addex Pharmaceuticals Addex Partner Starting Clinical Schizophrenia Trial Addex Partner Starting Clinical Schizophrenia Trial
2011-03-14 07:01:00 Switzerland Addex Pharmaceuticals Addex Converts Mandatory Convertible Notes and Issues Ordinary Shares Addex Converts Mandatory Convertible Notes and Issues Ordinary Shares
2011-03-09 07:01:00 Switzerland Addex Pharmaceuticals Addex Board Proposes Hoyoung Huh and Oleg Nodelman for Election to the Board of Directors Addex Board Proposes Hoyoung Huh and Oleg Nodelman for Election to the Board of Directors
2011-02-23 07:02:00 Switzerland Addex Pharmaceuticals Addex Pharmaceuticals 2010 Financial Results Addex Pharmaceuticals 2010 Financial Results
2011-02-18 16:00:00 Switzerland Addex Pharmaceuticals Addex Pharmaceuticals 2010 Financial Results Next Wednesday Addex Pharmaceuticals 2010 Financial Results Next Wednesday
2010-12-10 13:14:00 Switzerland Addex Pharmaceuticals Addex Awarded EuropaBio's Most Innovative SME Award Addex Awarded EuropaBio's Most Innovative SME Award
2010-11-12 18:01:00 Switzerland Addex Pharmaceuticals Addex Highlights Strength of Allosteric Modulation Technology Platform with Multiple Presentations at Society for Neuroscience 2010 Addex Highlights Strength of Allosteric Modulation Technology Platform with Multiple Presentations at Society for Neuroscience 2010
2010-09-08 00:02:00 Switzerland Addex Pharmaceuticals Addex Awarded Michael J. Fox Foundation Grant for ADX48621 to treat Levodopa-Induced Dyskinesia in Parkinson's Disease Addex Awarded Michael J. Fox Foundation Grant for ADX48621 to treat Levodopa-Induced Dyskinesia in Parkinson's Disease
2010-09-02 07:00:00 Switzerland Addex Pharmaceuticals Addex drug-candidate effective in Alzheimer's disease model Addex drug-candidate effective in Alzheimer's disease model
2010-07-28 07:00:00 Switzerland Addex Pharmaceuticals Addex Pharmaceuticals First Half 2010 Financial Results Addex Pharmaceuticals First Half 2010 Financial Results
2010-07-21 07:01:00 Switzerland Addex Pharmaceuticals Addex First Half 2010 Financial Results Next Wednesday Addex First Half 2010 Financial Results Next Wednesday
2010-07-13 07:01:00 Switzerland Addex Pharmaceuticals Addex drug candidate effective in osteoarthritis pain model Addex drug candidate effective in osteoarthritis pain model
2010-05-18 18:30:00 Switzerland Addex Pharmaceuticals Addex Executive Management Change Addex Executive Management Change
2010-05-11 07:02:00 Switzerland Addex Pharmaceuticals Addex R&D Day Highlights Addex R&D Day Highlights
2010-04-30 07:00:00 Switzerland Addex Pharmaceuticals Addex Shareholders Approve All Board Proposals at 2010 AGM Addex Shareholders Approve All Board Proposals at 2010 AGM
2010-04-28 18:00:00 Switzerland Addex Pharmaceuticals Addex to Host R&D Day on May 11 Addex to Host R&D Day on May 11
2010-02-23 07:01:00 Switzerland Addex Pharmaceuticals Addex Pharmaceuticals 2009 Financial Results Addex Pharmaceuticals 2009 Financial Results
2010-02-17 18:01:00 Switzerland Addex Pharmaceuticals Addex to Present at The New York Academy of Sciences Addex to Present at The New York Academy of Sciences
2010-02-16 17:33:00 Switzerland Addex Pharmaceuticals Addex to Host FY2009 Financial Results Conference Call on Feb. 23 Addex to Host FY2009 Financial Results Conference Call on Feb. 23
2010-02-08 07:00:00 Switzerland Addex Pharmaceuticals Addex: ADX71943 Demonstrates Analgesic Effects in Pain Models Addex: ADX71943 Demonstrates Analgesic Effects in Pain Models
2009-12-15 13:39:00 Switzerland Addex Pharmaceuticals Development of ADX10059 ended for long-term use Development of ADX10059 ended for long-term use
1| 2|
Reklama
?
Zacznij wprowadzać nazwę interesującego Cie waloru
Giełda na skróty
SPÓŁKI GPW
  • Popularne
    na forum
  • Ostatnio
    oglądane
  • Mój
    portfel
Walor Kurs Zm.[%] Obrót
[mln]
PETROLINV 1,18 -4,07 5,03
VICTORIA 0,04 +0,00 0,00
ANTI 0,69 -1,43 0,02
ANALIZATOR Znajdź SPÓŁKĘ
WIĘCEJ KRYTERIÓW
?
Wprowadź listę symboli lub nazw walorów, które chcesz porównać na wykresie, rozdzielając je przecinkami.

W trakcie wypełniania pola, system będzie podpowiadał nazwy dostępnych walorów - możesz wybrać je z utworzonej listy.
Money analytics
money analytics